The Pfizer COVID-19 vaccine, marketed as Comirnaty, contains a small piece of genetic code called mRNA wrapped in a protective fatty shell, along with salts, sugars, and buffers that keep the formula stable. Each adult dose delivers 30 micrograms of mRNA in a 0.3 mL injection. That’s the full picture: genetic instructions, a delivery system, and stabilizers. No preservatives, no mercury, no fetal tissue.
The Active Ingredient: Modified mRNA
The core of the vaccine is a strand of nucleoside-modified messenger RNA, or modRNA. This molecule carries instructions that tell your cells to build copies of the spike protein found on the surface of the SARS-CoV-2 virus. Your immune system recognizes the spike protein as foreign, mounts a response against it, and remembers it for later. The mRNA itself breaks down within days and never enters the nucleus of your cells where DNA is stored.
The “nucleoside-modified” part matters. Scientists chemically tweaked some of the building blocks of the mRNA so that your body’s immune defenses wouldn’t destroy it before it had a chance to do its job. This modification is what allowed the vaccine to work efficiently at such a small dose.
The specific strain targeted by the mRNA changes over time, much like the flu shot updates annually. The 2025-2026 formula encodes the spike protein from the Omicron LP.8.1 sublineage, part of the JN.1 family of variants. The FDA selects the strain each year based on which versions of the virus are circulating most widely.
The Lipid Nanoparticle Shell
Raw mRNA is fragile. Left unprotected, it would be shredded by enzymes in your body before reaching a single cell. To solve this, the mRNA is wrapped in lipid nanoparticles, essentially tiny bubbles made of four different fats. These particles serve two purposes: they shield the mRNA during transit and help it slip inside your cells, where it can be read and translated into the spike protein.
Two of the four lipids are naturally occurring compounds similar to fats already found in your body. A third is a cholesterol-like molecule that adds structural stability to the bubble. The fourth is a polyethylene glycol (PEG)-lipid that prevents the nanoparticles from clumping together. PEG is the one component that has been linked to rare allergic reactions in people with a known PEG sensitivity.
Salts, Sugars, and Buffers
The remaining ingredients are common stabilizers you’d find in many injectable medications. Sucrose (ordinary table sugar) acts as a cryoprotectant, preventing the lipid nanoparticles from being damaged during freezing and thawing. Without it, the delicate fatty shells could crack apart at ultra-low temperatures.
The vaccine also contains buffer salts that keep the solution at the right pH, which is critical for stability. The original adult formulation used a phosphate-buffered saline (PBS) system. Pfizer later transitioned to a Tris-sucrose buffer system, first introduced in the pediatric formulation for children ages 5 through 11. The FDA confirmed analytical comparability between the two formulations, meaning the switch did not change how the vaccine performs. The Tris-based buffer improved the vaccine’s shelf life and made storage logistics simpler.
What’s Not in the Vaccine
The Pfizer vaccine does not contain any preservatives. It contains no thimerosal (the mercury-based preservative that was once common in multi-dose flu vaccines and sparked years of unfounded safety debates). There is no formaldehyde, no latex in the vial or its packaging, and no fetal cell material. The vaccine is also egg-free and gelatin-free.
One question that has come up is residual DNA from the manufacturing process. The mRNA is produced using a DNA template, and trace fragments of that template can remain in the final product. The FDA states that internationally agreed-upon limits govern how much residual DNA is allowed in any biological product, and the COVID-19 mRNA vaccines fall well within those limits. Specifically, the quantity of residual DNA fragments after enzymatic cleanup is more than a thousand times lower than the weight of the mRNA dose itself. Each production lot is tested with a validated assay to confirm compliance.
Dosing by Age Group
Adults and adolescents 12 and older receive 30 micrograms of mRNA per dose. Younger children receive lower doses. The reduction isn’t just a smaller volume of the same liquid; the pediatric versions were specifically formulated at lower concentrations and, as noted, use the updated Tris-sucrose buffer. The goal is to deliver enough mRNA to trigger a strong immune response while minimizing side effects in smaller bodies.
Why It Needs Ultra-Cold Storage
mRNA is inherently unstable, which is why the vaccine originally required storage between -80°C and -60°C (-112°F to -76°F) in specialized ultra-low temperature freezers. This was one of the biggest logistical challenges during the initial rollout. Once thawed, undiluted vials could be refrigerated for up to five days, and after dilution, the vaccine had to be used within six hours at either refrigerator or room temperature.
The reformulation with Tris-sucrose buffer improved thermal stability, allowing more flexible handling in pharmacies and clinics. Still, the vaccine remains more temperature-sensitive than most routine immunizations, which is why you’ll notice the pharmacist pulling it from cold storage right before your appointment.